CRIS Current Research Information System

CAVALLI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.632
EU - Europa 10.215
AS - Asia 5.318
AF - Africa 671
SA - Sud America 50
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 20
Totale 30.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.574
GB - Regno Unito 2.834
IT - Italia 2.383
CN - Cina 1.867
SG - Singapore 1.330
DE - Germania 1.286
VN - Vietnam 1.070
SE - Svezia 862
UA - Ucraina 764
IN - India 683
FR - Francia 440
IE - Irlanda 426
RU - Federazione Russa 341
TG - Togo 224
EE - Estonia 205
ZA - Sudafrica 201
CI - Costa d'Avorio 123
HR - Croazia 101
JO - Giordania 101
CH - Svizzera 100
ES - Italia 77
BG - Bulgaria 73
SC - Seychelles 60
FI - Finlandia 55
NL - Olanda 50
JP - Giappone 48
NG - Nigeria 48
BE - Belgio 43
CA - Canada 43
HK - Hong Kong 38
GR - Grecia 37
BR - Brasile 34
CZ - Repubblica Ceca 34
ID - Indonesia 31
AU - Australia 27
PL - Polonia 27
RO - Romania 25
KR - Corea 24
IR - Iran 23
TW - Taiwan 22
AT - Austria 21
TR - Turchia 20
EU - Europa 17
PK - Pakistan 15
CL - Cile 11
LB - Libano 9
BZ - Belize 8
PH - Filippine 8
EG - Egitto 7
LV - Lettonia 7
PT - Portogallo 7
MX - Messico 6
MY - Malesia 6
NO - Norvegia 6
HU - Ungheria 4
IL - Israele 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
BO - Bolivia 3
LK - Sri Lanka 3
MD - Moldavia 3
UZ - Uzbekistan 3
DZ - Algeria 2
IQ - Iraq 2
MU - Mauritius 2
NA - Namibia 2
NZ - Nuova Zelanda 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 30.935
Salva come PNG Salva come JPEG
Città #
Southend 2.493
Fairfield 1.947
Singapore 1.165
Ashburn 1.139
Chandler 983
Woodbridge 946
Seattle 868
Wilmington 865
Houston 806
Santa Clara 759
Ann Arbor 744
Dong Ket 718
Bologna 662
Cambridge 660
Princeton 628
Jacksonville 490
Dublin 423
Boardman 405
Westminster 261
Nanjing 259
Padova 245
Lomé 224
Berlin 198
Milan 133
Saint Petersburg 133
Jinan 132
Abidjan 123
San Diego 116
Shenyang 113
Redmond 111
Beijing 108
Amman 101
Mülheim 93
Hebei 92
Nanchang 87
Medford 83
New York 77
Changsha 76
Falls Church 71
Tianjin 68
Sofia 67
Des Moines 59
Guangzhou 58
Dearborn 52
Norwalk 51
Mahé 50
Shanghai 50
Turin 47
Abeokuta 44
Zhengzhou 44
Rome 43
Verona 43
Helsinki 41
Olalla 41
Bern 40
Brussels 39
Redwood City 38
Ningbo 36
Los Angeles 35
Jiaxing 34
Barcelona 33
Genoa 33
Tokyo 32
Chicago 30
Hangzhou 30
Jakarta 29
Pune 29
Haikou 28
Genova 26
Lanzhou 26
Mountain View 26
Paris 26
Taizhou 26
Brno 24
Frankfurt am Main 24
Bari 22
Hyderabad 22
Kunming 22
Modena 22
Phoenix 22
Taiyuan 22
Amsterdam 21
Council Bluffs 21
Fremont 21
San Jose 21
Bremen 20
Wuhan 20
London 19
Shenzhen 19
Bühl 18
Florence 18
Zurich 18
San Venanzo 17
Bengaluru 16
Fuzhou 16
Stockholm 15
Ferrara 13
Mumbai 13
Xi'an 13
Harbin 12
Totale 21.402
Salva come PNG Salva come JPEG
Nome #
A small molecule targeting the multifactorial nature of Alzheimer's disease 288
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 264
La metadinamica nello studio dell'energia libera di complessi recettoriali binari 232
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2AReceptor Subtype 221
A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: structure-based design, synthesis, and biological evaluation 208
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 194
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer 193
An automated docking protocol for HERG channel blockers. 189
A Catalytic Mechanism for Cysteine N-Terminal Nucleophile Hydrolases, as Revealed by Free Energy Simulations 188
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 185
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 182
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 179
A molecular dynamics study of reovirus attachment protein sigma1 reveals conformational changes in sigma1 structure 176
Computational design and discovery of "minimally structured" hERG blockers. 175
Dynamic Docking: A Paradigm Shift in Computational Drug Discovery 157
BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease 157
Antiproliferative agents that interfere with the cell cycle at the G(1)-->S transition: further development and characterization of a small library of stilbene-derived compounds 154
Protein Tunnels: The Case of Urease Accessory Proteins 154
Analogues of the dual acetylcholinesterase inhibitor AP2238: synthesis and SAR 153
Synthetic Lethality through the Lens of Medicinal Chemistry 152
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues 151
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 150
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 149
AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets 148
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 145
Polyamine conjugation of curcumin analogues toward the discovery of mitochondria-directed neuroprotective agents. 145
Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach 144
Assessment of capillary volumetric blood microsampling for the analysis of central nervous system drugs and metabolites 144
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 143
Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening 143
Curcumin analogs as multi-target antioxidants: focus on mitochondria. 142
Parallel Synthesis, Evaluation, and Preliminary Structure-Activity Relationship of 2,5-Diamino-1,4-benzoquinones as a Novel Class of Bivalent Anti-Prion Compound. 140
Application of Conformational Clustering in Protein–Ligand Docking 140
Computational approaches to the study of dual-site and peripheral site binding ache inhibitors 139
AN INNOVATIVE PROTOCOL FOR COMPARING PROTEIN BINDING SITES VIA ATOMIC GRID MAPS 139
Combining Dyad Protonation and Active Site Plasticity in BACE-1 Structure-Based Drug Design 137
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates 137
A Computational Study of the Binding of Propidium to the Peripheral Anionic Site of Human Acetylcholinesterase 137
null 136
Binding Residence Time through Scaled Molecular Dynamics: A Prospective Application to hDAAO Inhibitors 136
Role of Molecular Dynamics and Related Methods in Drug Discovery 136
A comparative study on the application of hierarchical-agglomerative clustering approaches to organize outputs of reiterated docking runs. 135
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 134
Whole blood and oral fluid microsampling for the monitoring of patients under treatment with antidepressant drugs 132
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 129
Hybrid Lipoic Acid Derivatives to Attack Prion Disease on Multiple Fronts 128
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 128
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach 127
Covalent Inhibitors of Fatty Acid Amide Hydrolase: A Rationale for the Activity of Piperidine and Piperazine Aryl Ureas 126
Density Functional Studies on the Nazarov Reaction Involving Cyclic Systems. 125
Multitargeted drugs for the treatment of Alzheimer's disease 124
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 124
A theoretical investigation of the (0001) covellite surfaces. 124
null 123
Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex 123
Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks 123
Bivalent tacrine-based acetylcholinesterase inhibitors: role of the spacer in the recognition process of the enzyme gorge 122
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 122
Systematic Exploitation of Multiple Receptor Conformations for Virtual Ligand Screening 121
null 121
Exploring complex protein-ligand recognition mechanisms with coarse metadynamics 121
In silico modelling--pharmacophores and hERG channel models 120
Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease 120
A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase 120
Multitarget Drug Discovery and Polypharmacology 120
In vivo characterization of ARN14140, a memantine/galantamine-based multi-target compound for Alzheimer's disease 120
Computational study of the phosphoryl transfer catalyzed by a cyclin-dependent kinase 119
Monolithic stationary phase coupled with coulometric detection: development of an ion-pair HPLC method for the analysis of quinone-bearing compounds. 119
Cu3-xP Nanocrystals as a Material Platform for Near-Infrared Plasmonics and Cation Exchange Reactions 118
null 118
Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment 118
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 117
Kernel-Based, Partial Least Squares Quantitative Structure-Retention Relationship Model for UPLC Retention Time Prediction: A Useful Tool for Metabolite Identification 117
Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity 117
Characterization of Cholinesterase inhibitors by means of immobilized enzyme reactor 116
Docking ligands on protein surfaces: the case study of prion protein. 116
An Advanced Multiple Receptor Conformations Virtual Ligand Screening Protocol for the Identification of Novel BACE-1 Inhibitors 116
Investigating Drug-Target Residence Time in Kinases through Enhanced Sampling Simulations 116
Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors 115
Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia 115
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 115
Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. 114
Mapping cholesterol interaction sites on serotonin transporter through coarse-grained molecular dynamics 114
The role of Li(+), Na(+), and K(+) in the ligand binding inside the human acetylcholinesterase gorge 113
Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania 113
Multitarget Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania 113
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme 112
Heterocyclic inhibitors of AChE acylation and peripheral sites. 112
Blood microsampling for untargeted lipidomics 112
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases 111
Benzophenone derivatives as Inhibitors of Acetylcholinesterase 111
Allosteric Modulation of Alpha7 Nicotinic Receptors: Mechanistic Insight through Metadynamics and Essential Dynamics 111
BiKi Life Sciences: A New Suite for Molecular Dynamics and Related Methods in Drug Discovery 111
Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease 111
Computational drug discovery under RNA times 110
Target-related applications of first principles quantum chemical methods in drug design 110
Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase 110
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 110
Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease. 110
In silico antitarget screening 110
Totale 13.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.807 0 0 0 0 758 761 974 1.076 1.011 543 230 454
2020/20214.800 842 354 173 208 204 497 90 294 376 259 259 1.244
2021/20225.060 587 151 355 274 488 354 147 421 286 264 802 931
2022/20235.273 562 775 280 619 420 335 183 318 914 205 377 285
2023/20242.235 164 298 138 179 217 317 163 164 75 159 187 174
2024/20253.931 316 1.142 739 450 1.284 0 0 0 0 0 0 0
Totale 31.650